Clinical Trial Update: Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of cytarabine and UCN-01 in patients with refractory or relapsed acute myeloid leukemia or myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED